Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneum01:21

Peritoneum

12.8K
The peritoneum is a vital membrane that lines the abdominal cavity and covers most of the organs within it. It plays a crucial role in protecting the organs, providing a smooth surface for their movement, and facilitating various physiological processes. Understanding the anatomy and function of the peritoneum is essential for comprehending the complexities of the abdominal region.
Anatomy of the Peritoneum
The peritoneum is divided into two layers: the parietal peritoneum and the visceral...
12.8K
Ascites01:19

Ascites

47
DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
47
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

2.1K
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
2.1K
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

758
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
758
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

8.5K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
8.5K
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

586
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
586

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paclitaxel-Coated Balloon Therapy for Refractory Ureteral Stenosis in a Kidney Transplant Recipient.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

From Guillain-Barré-Like Neuropathy to EGPA: ANCA Testing and Kidney Biopsy as Diagnostic Turning Points.

Nephrology (Carlton, Vic.)·2026
Same author

Cryopreserved vascular allografts for venous lengthening after robot-assisted living donor nephrectomy: a single institution experience.

Frontiers in surgery·2026
Same author

Hemoglobinuria-associated acute kidney injury in hemolytic uremic syndrome without renal thrombotic microangiopathy.

BMC nephrology·2026
Same author

Beyond the Score Study: Retrospective Analysis of Single-Graft Kidney Transplant with Karpinski Score 4 Versus Score 5 Grafts.

Medicina (Kaunas, Lithuania)·2025
Same author

Efficacy and safety of rituximab and low dosage of glucocorticoids for ANCA associated vasculitis interstitial lung disease: a proof-of-concept study.

Respiratory medicine·2025

Related Experiment Video

Updated: May 5, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K

Encapsulating peritoneal sclerosis.

Guido Garosi1, Nicoletta Mancianti, Roberto Corciulo

  • 1Nephrology and Dialysis Unit, University Hospital of Siena, Siena - Italy.

Journal of Nephrology
|December 6, 2013
PubMed
Summary
This summary is machine-generated.

Encapsulating peritoneal sclerosis (EPS) management involves medical therapies like steroids and mTOR inhibitors, alongside surgical evaluation for severe cases. Prevention strategies focus on peritonitis control and optimized peritoneal dialysis practices.

More Related Videos

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

1.9K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.0K

Related Experiment Videos

Last Updated: May 5, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K
A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

1.9K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.0K

Area of Science:

  • Nephrology
  • Gastroenterology
  • Transplantation

Background:

  • Encapsulating peritoneal sclerosis (EPS) is a serious complication of peritoneal dialysis (PD).
  • Current understanding and management strategies for EPS require updates.
  • There is a need for clear guidelines on EPS treatment and prevention.

Purpose of the Study:

  • To define current consensus on encapsulating peritoneal sclerosis (EPS).
  • To highlight recent advancements in EPS management.
  • To outline future research directions for EPS.

Main Methods:

  • Review of current medical therapies including steroids, tamoxifen, sirolimus, and everolimus.
  • Discussion of surgical assessment indications for patients with intestinal symptoms.
  • Analysis of preventive measures such as peritonitis management and biocompatible dialysis fluids.

Main Results:

  • Medical therapy options include steroids, tamoxifen, sirolimus/everolimus, requiring prolonged treatment (≥6 months) due to relapse risk.
  • Surgical assessment is crucial for patients with intestinal symptoms or subocclusion.
  • Effective prevention of EPS remains a challenge, with ongoing research into optimal dialysis fluid and membrane transport monitoring.

Conclusions:

  • Established medical and surgical approaches offer therapeutic options for EPS.
  • Prevention strategies require further investigation and consensus.
  • Personalized immunosuppressive protocols and prophylactic tamoxifen may reduce EPS risk in specific patient populations.